Methylnaphthidate

===Forms & Identification=== Methylnaphthidate circulates exclusively through [[glossary:novel-psychoactive-substance|research chemical]] vendors, typically as a powder or crystalline solid. No pharmaceutical formulations exist. Because the compound has never been manufactured under any quality standard, batch purity and identity cannot be assumed — [[glossary:reagent-kit|reagent testing]] is essential for every acquisition, and even positive reagent results confirm only the presence of a compound class, not purity or dose accuracy. Volumetric dosing from a prepared solution is strongly recommended over attempting to weigh individual doses of powder. The [[glossary:dose-range|active dose range]] is low enough that imprecision from a milligram scale can meaningfully alter the experience and risk profile. ===Set & Setting=== As a [[substance_class:psychoactive/stimulant]] with reinforcing [[glossary:efficacy]] comparable to [[substance:cocaine]] in [[glossary:animal-model|animal models]], methylnaphthidate warrants particular attention to the psychological context of use. A clear intention for the session — whether functional or recreational — and a predetermined endpoint reduce the risk of compulsive [[glossary:redose|redosing]], which is the primary behavioral hazard of potent [[substance_class:pharmacological/dopamine-reuptake-inhibitor|dopamine reuptake inhibitors]]. Physical environment matters for cardiovascular safety: avoid hot environments, sustained [[glossary:physical-exertion]], and [[glossary:dehydration]], all of which amplify the cardiovascular strain from catecholaminergic [[effect:stimulation]]. {{Guideline}} ==== Guidelines= === * Test every batch with appropriate reagent kits before use * Use volumetric dosing rather than weighing individual doses of powder * Start with a low dose and wait for full onset before considering redosing — oral onset may take up to 10 minutes * Set a firm limit on total dose and number of redoses before the session begins * Keep the compound out of arm's reach during the session to reduce impulsive redosing * Avoid [[glossary:insufflation]] if possible — the compressed, intensified onset increases reinforcing potential and cardiovascular strain * Ensure access to water and a cool environment * Do not use on consecutive days; allow at least 48 hours between sessions * Do not combine with other stimulants, serotonergic substances, or [[substance:alcohol]] {{/Guideline}} {{Emergency}} ==== Emergency Response= === Recognizing an emergency: [[glossary:chest-pain]], severe [[effect:headache]], [[glossary:seizure]], [[glossary:loss-of-consciousness]], extreme [[glossary:agitation]] with [[effect:confusion]], or [[glossary:body-temperature]] hot to the touch through clothing all indicate a medical emergency rather than ordinary discomfort. * 1. Call emergency services immediately if any of the above signs are present * 2. Place the person in a cool, quiet environment while waiting for help * 3. If unconscious but breathing, place in the [[glossary:recovery-position]] (on their side, [[glossary:airway]] clear) * 4. Do not restrain an agitated person unless they are at immediate risk of [[glossary:self-harm]] * 5. Do not induce [[effect:vomiting]] * 6. Monitor breathing continuously until help arrives Tell the dispatcher: the substance name (methylnaphthidate or HDMP-28), the approximate amount taken, the time of last dose, the [[glossary:route-of-administration]], and current symptoms. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect people who call for help during a [[glossary:drug-emergency]]. No reversal agent exists for stimulant [[glossary:overdose]]. {{/Emergency}} {{Aftercare}} ==== Aftercare & Integration= === The post-stimulation period following methylnaphthidate use typically involves a [[glossary:rebound-effect]] phase — low mood, [[glossary:fatigue]], [[effect:irritability]], and difficulty concentrating — driven by temporary [[glossary:dopamine]] [[glossary:depletion]]. This is a predictable pharmacological consequence, not a sign of lasting damage. Prioritize sleep, [[glossary:hydration]], and regular meals in the 24–48 hours following use. Avoid [[substance:caffeine]] and other stimulants during the comedown, as they mask fatigue without addressing the underlying neurochemical rebound. If low mood persists beyond 72 hours, or if [[effect:craving|cravings]] to redose feel difficult to manage, consider speaking with a healthcare provider or counselor. {{/Aftercare}} {{Recovery}} ==== Recovery & Support= === The reinforcing efficacy data for methylnaphthidate suggest that regular use carries meaningful risk of developing a compulsive pattern. If use has escalated in frequency or dose, or if attempts to stop have been unsuccessful, structured support is appropriate. Resources include SAMHSA's National Helpline (1-800-662-4357, US), SMART Recovery, and local [[glossary:addiction]] services. [[glossary:substance-use-disorder|Stimulant use disorders]] respond to cognitive-behavioral therapy and contingency management; no pharmacological treatment for stimulant [[glossary:dependence]] is established, making behavioral approaches the primary recovery pathway. {{/Recovery}}

===Forms & Identification=== Methylnaphthidate circulates exclusively through [[glossary:novel-psychoactive-substance|research chemical]] vendors as a powder or crystalline solid. No pharmaceutical formulations exist. Batch purity and identity cannot be assumed — test every acquisition with appropriate [[glossary:reagent-kit|reagent kits]], and note that a positive result confirms only the compound class, not purity or dose accuracy. Volumetric dosing — dissolving a weighed quantity in a measured volume of liquid and dosing by volume — is strongly preferred over weighing individual powder doses. The [[glossary:dose-range|active dose range]] is narrow enough that milligram-scale imprecision meaningfully affects both the experience and the risk. ===Set & Setting=== With reinforcing [[glossary:efficacy]] comparable to [[substance:cocaine]] in [[glossary:animal-model|animal models]], methylnaphthidate warrants careful attention to the psychological context of use. A clear intention and a predetermined endpoint reduce the risk of compulsive [[glossary:redose|redosing]] — the primary behavioral hazard of potent [[substance_class:pharmacological/dopamine-reuptake-inhibitor|dopamine reuptake inhibitors]]. Avoid hot environments, sustained [[glossary:physical-exertion]], and [[glossary:dehydration]]. All amplify cardiovascular strain from catecholaminergic [[effect:stimulation]]. {{Guideline}} ==== Guidelines= === * Test every batch with appropriate reagent kits before use * Use volumetric dosing rather than weighing individual doses of powder * Start with a low dose and wait for full onset before considering redosing — oral onset may take up to 10 minutes * Set a firm limit on total dose and number of redoses before the session begins * Keep the compound out of arm's reach during the session to reduce impulsive redosing * Avoid [[glossary:insufflation]] if possible — the compressed, intensified onset increases reinforcing potential and cardiovascular strain * Ensure access to water and a cool environment * Do not use on consecutive days; allow at least 48 hours between sessions * Do not combine with other [[substance_class:psychoactive/stimulant|stimulants]], serotonergic substances, or [[substance:alcohol]] {{/Guideline}} {{Emergency}} ==== Emergency Response= === Recognizing an emergency: [[glossary:chest-pain]], severe [[effect:headache]], [[glossary:seizure]], [[glossary:loss-of-consciousness]], extreme [[glossary:agitation]] with [[effect:confusion]], or [[glossary:body-temperature]] hot to the touch through clothing all indicate a medical emergency rather than ordinary discomfort. * 1. Call emergency services immediately if any of the above signs are present * 2. Place the person in a cool, quiet environment while waiting for help * 3. If unconscious but breathing, place in the [[glossary:recovery-position]] (on their side, [[glossary:airway]] clear) * 4. Do not restrain an agitated person unless they are at immediate risk of [[glossary:self-harm]] * 5. Do not induce [[effect:vomiting]] * 6. Monitor breathing continuously until help arrives Tell the dispatcher: the substance name (methylnaphthidate or HDMP-28), the approximate amount taken, the time of last dose, the [[glossary:route-of-administration]], and current symptoms. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect people who call for help during a [[glossary:drug-emergency]]. No reversal agent exists for stimulant [[glossary:overdose]]. {{/Emergency}} {{Aftercare}} ==== Aftercare & Integration= === The post-stimulation period typically brings low mood, [[glossary:fatigue]], [[effect:irritability]], and difficulty concentrating — a predictable [[glossary:dopamine]] [[glossary:rebound-effect]], not a sign of lasting damage. Prioritize sleep, [[glossary:hydration]], and regular meals in the 24–48 hours following use. Avoid [[substance:caffeine]] and other stimulants during the comedown. If low mood persists beyond 72 hours, or [[effect:craving|cravings]] feel difficult to manage, speak with a healthcare provider or counselor. {{/Aftercare}} {{Recovery}} ==== Recovery & Support= === The reinforcing efficacy data suggest regular use carries meaningful risk of developing a compulsive pattern. If use has escalated in frequency or dose, or attempts to stop have been unsuccessful, structured support is appropriate. Resources include SAMHSA's National Helpline (1-800-662-4357, US), SMART Recovery, and local [[glossary:addiction]] services. [[glossary:substance-use-disorder|Stimulant use disorders]] respond to cognitive-behavioral therapy and contingency management; no pharmacological treatment is established, making behavioral approaches the primary recovery pathway. {{/Recovery}}